| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-15 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.2 | 1e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |